成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Avelumab (Anti-Human PD-L1, Human Antibody),Avelumab (Anti-Human PD-L1, Human Antibody)
  • Avelumab (Anti-Human PD-L1, Human Antibody),Avelumab (Anti-Human PD-L1, Human Antibody)

1537032-82-8Avelumab

價格 詢價
包裝 1盒
最小起訂量 1盒
發(fā)貨地 上海
更新日期 2024-12-23
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:Avelumab (Anti-Human PD-L1, Human Antibody)英文名稱:Avelumab (Anti-Human PD-L1, Human Antibody)
CAS:1537032-82-8品牌: 一研
保存條件: Store at -20°C產(chǎn)品類別: 抑制劑
Cas : 1537032-82-8
2024-12-23 Avelumab (Anti-Human PD-L1, Human Antibody) Avelumab (Anti-Human PD-L1, Human Antibody) 1盒/RMB 一研 Store at -20°C 抑制劑

產(chǎn)品屬性:

產(chǎn)品名稱

規(guī)格

CAS

型號

Avelumab (Anti-Human PD-L1, Human Antibody)

1mg 5mg 20mg

1537032-82-8

EY-Y0165104

Cas No.1537032-82-8

別名 N/A

化學名 N/A

分子式 N/A

Avelumab (Anti-Human PD-L1, Human Antibody).png

分子量 N/A

溶解度 Soluble in DMSO

儲存條件 Store at -20°C
General tips  For obtaining a higher solubility , please warm the tube at 37 and shake it in the ultrasonic bath for a while.
Shipping Condition     Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.

Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity property. Avelumab increases NK-cell lysis 3.1-fold (P=0.01) in JHC7 cells relative to isotype control. When the cells are treated with IFN-γ, Avelumab markedly enhances NK-cell lysis relative to isotype control in the following cell lines: JHC7 (7.56-fold; P=0.001), UM-Chor1 (7.34-fold; P<0.001), U-CH2 (2.6 fold; P=0.008), MUG-Chor1 (8.38-fold; P=0.0016). Avelumab effectively increases antibody-dependent cell-mediated cytotoxicity (ADCC) of both the non-cancer stem cell (CSC) and CSC subpopulations to the same degree[1]. Results also demonstrate that the addition of Avelumab increases the frequency of antigen-specific multifunctional CD8+ T cells by more than fivefold, relative to the isotype control in CEFT-stimulated peripheral blood mononuclear cells (PBMCs)[2].

Measurement of individual tumors clearly shows a slowing of tumor growth in the Avelumab-treated mice. By day 36 post-tumor implantation, there is a significant (P<0.01) reduction in the average tumor volume of the Avelumab-treated mice. Reduction in MB49 tumor growth in the mice treated with Avelumab is durable and leads to a significant (P<0.05) improvement in percent survival. Avelumab treatment of 10 mice with bladder tumors results in complete tumor regression in 8 mice, confirmed by histopathology. However, in mice depleted of either CD4 or CD8 cells, Avelumab treatment is much less effective in controlling bladder tumor burden with tumor breakthrough occurring in a higher frequency in mice depleted of CD4 T cells[3].

[1]. Fujii R, et al. Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget. 2016 Jun 7;7(23):33498-511. [2]. Grenga I, et al. A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses. Clin Transl Immunology. 2016 May 20;5(5):e83. [3]. Vandeveer AJ, et al. Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res. 2016 May;4(5):452-62.


關鍵字: 1537032-82-8;N/A;Avelumab (Anti-Human;

公司簡介

上海一研生物科技有限公司Shanghai yiyan bio-technology Co. Ltd.主要從事免疫學、分子生物學和常規(guī)生化試劑等為一體的科研產(chǎn)品銷售企業(yè),公司自成立以來,秉承""全心全意服務于科研工作者""的企業(yè)理念,立足生物科技領域,運用生物技術和科研試劑,發(fā)展現(xiàn)代生物科技,為各類大中小醫(yī)院及其它醫(yī)療機構、高等院校、科研院所、企事業(yè)單位提供優(yōu)質(zhì)的產(chǎn)品,服務生物科技領域的科學研究人員。 公司具有對普通貨物、冷藏及冷凍倉庫的存儲、包裝及運輸能力。 公司將始終堅持信譽立業(yè)、以人為本、質(zhì)量保證、誠信服務的宗旨,不斷拼搏,開拓進取,與各界朋友攜手共創(chuàng)美好未來。
成立日期 2014-06-05 (11年) 注冊資本 100
員工人數(shù) 50-100人 年營業(yè)額 ¥ 100萬以內(nèi)
主營行業(yè) 生化試劑,抗體,細胞培養(yǎng),分子生物學,免疫安全 經(jīng)營模式 工廠,試劑
  • 上海一研生物科技有限公司
VIP 3年
  • 公司成立:11年
  • 注冊資本:100
  • 企業(yè)類型:營業(yè)執(zhí)照
  • 主營產(chǎn)品:、ELISA試劑盒、PCR檢測試劑盒、生化檢測試劑盒、標準品、抗體、細胞等
  • 公司地址:上海市閔行區(qū)莘福路2號樓
詢盤

1537032-82-8Avelumab相關廠家報價

更多
產(chǎn)品名稱 價格   公司名稱 報價日期
詢價
VIP3年
武漢佰樂博生物技術有限公司
2024-12-20
¥5780
VIP3年
TargetMol中國(陶術生物)
2024-12-12
¥4959.90
VIP1年
上海阿拉丁生化科技股份有限公司
2024-11-29
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實性、準確性和合法性由發(fā)布商家負責。 商家發(fā)布價格指該商品的參考價格,并非原價,該價格可能隨著市場變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價格,請咨詢商家,以實際成交價格為準。請意識到互聯(lián)網(wǎng)交易中的風險是客觀存在的
主頁 | 企業(yè)會員服務 | 廣告業(yè)務 | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 |投訴中心
Copyright ? 2008 ChemicalBook 京ICP備07040585號  京公海網(wǎng)安備110108000080號  All rights reserved.
400-158-6606